Johnson & Johnson (JNJ) vs The Procter & Gamble Company (PG)
See how Johnson & Johnson and The Procter & Gamble Company differ across market data and performance, so you can decide which asset best fits your strategy.
$253.74
NYSE
Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.
View Full Page$156.28
NYSE
Founded in 1837, Procter & Gamble Company (PG) has grown into one of the world’s largest consumer goods manufacturers, generating nearly $85 billion in annual sales. Its portfolio includes many leading brands, with more than 20 producing over $1 billion in global annual revenue each, including Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. International markets account for slightly more than half of the company’s consolidated sales.
View Full PageKey Metrics Comparison
Johnson & JohnsonJNJ
Market Cap$611.488B
Price$253.74
24h Change+2.06%
24h Volume$5.5M
Employees138,200
Shares Outstanding2,407,216,971
The Procter & Gamble CompanyPG
Market Cap$363.262B
Price$156.28
24h Change+2.12%
24h Volume$5.27M
Employees109,000
Shares Outstanding2,328,598,978
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
JNJ
62.7%PG
37.3%Volume Share
Share of combined 24h volume
JNJ
51.1%PG
48.9%24h Performance
Price change over last 24 hours
JNJ
2.06%PG
2.12%Price Comparison
Johnson & Johnson
The Procter & Gamble Company